Back to search

Sweden· SE-20040604000062

Alfuzosin Sandoz 10 mg Depottablett

A alfuzosin product containing alfuzosin hydrochloride, registered in Sweden by Sandoz A/S. The same ATC class is registered in 18 of our 19 countries.

ATC G04CA01

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedAlfuzosin Sandoz 10 mg DepottablettATCG04CA01REGISTER NO.SE-20040604000062PACKS LISTED1CHECKEDOctober 1, 2026

Where it is registered

Alfuzosin is registered in 18 of 19 countries.

Countries holding a registration under ATC G04CA01 (alfuzosin), each read from that country’s own register.

  • This record: Sweden, from Swedish Medical Products Agency (Sweden)
  • 11 of them publish a price we can compare per daily dose

Alfuzosin · ATC G04CA01

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfuzosin costs, country by country.

Normalised to the WHO defined daily dose (7.5 mg), the median price runs from $0.25 in France to $0.93 in Switzerland — a ×3.7 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Alfuzosin · price per daily dose (7.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.93
  • ES Spain$0.34
  • IT Italy$0.25
  • FR France$0.25
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Alfuzosin Hydrochloride
Manufacturer
Sandoz A/S
Country
Sweden (SE)
ATC code
G04CA01
ATC class
Alfuzosin
Defined daily dose
7.5 mg, O
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20040604000062

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

330 interactions on record for alfuzosin.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alfuzosin · interactions on record

330 records

  • 47 severe
  • 182 moderate
  • 3 minor
  • 48 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • PapaverinC04AX38severe

50 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alfuzosin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alfuzosin products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Alfuzosin Stada
  • Belgium · Alfuzosine Sandoz, Xatral Retard
  • Cyprus · Alfural, Alfuzosin Aurobindo
  • Czechia · Alfuzosin Viatris
  • Germany · Alfuzosin, Alfuzosin 10 1 A Pharma
  • Denmark · Alfuzosin Orion, Alfuzosin Sandoz
  • Estonia · Alfuzosin Teva, Xatral Sr
  • Spain · Alfuzosina Aurovitas, Alfuzosina Stada
  • Finland · Alfuzosin Hydrochlorid Ratiopharm, Alfuzosin Hydrochloride Orion
  • France · Alfuzosine, Alfuzosine L.P Eg
  • United Kingdom (Northern Ireland) · Alfuzosin Hcl Milpharm, Alfuzosin Hydrochloride Teva Uk
  • Greece · Alcinin, Alfudex
  • Hungary · Alfetim Sr, Alfetim Uno
  • Ireland · Alfu, Xatger
  • Iceland · Alfuzosin Hydrochloride Alvogen
  • Italy · Alfuzosin Ratiopharm, Alfuzosina Aurobindo
  • Lithuania · Xatral Sr
  • Luxembourg · Xatral Uno
  • Latvia · Alfuzosin Teva, Xatral Sr
  • Malta · Zochek
  • Netherlands · Alfuzosine Hcl Aurobindo, Alfuzosine Hcl Cf
  • Poland · Alfabax, Alfurion
  • Portugal · Alfuzosin Teva, Alfuzosina Aurovitas
  • Romania · Xatral Sr
  • Slovakia · Alfuzosin Sandoz, Alfuzosin Viatris

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1dcfecda-5df7-47ca-a07c-943ff37d0d1b
GET /v1/drugs/1dcfecda-5df7-47ca-a07c-943ff37d0d1b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL",
    "PAR"
  ],
  "se_npl_id": "20040604000062",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20040604000062",
  "product_doc_link": "https://docetp.mpa.se/LMF/Alfuzosin%20Sandoz%2010%20mg%20prolonged-release%20tablet%20SmPC_09001bee807a1f6f.pdf"
}

See everything about alfuzosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.